Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hurri-Freeze
- Development stage
- Unknown
- Lead developer
- Nuance Medical
- Administration
- Topical
01
Overview
Hurri-Freeze is a topical anesthetic skin refrigerant (vapo-coolant) used to provide immediate, temporary numbing of the skin prior to minor surgical procedures, injections, or venipuncture. Developed by Beutlich Pharmaceuticals and currently marketed by Nuance Medical, it consists of a blend of 1,1,1,3,3-pentafluoropropane and 1,1,1,2-tetrafluoroethane. The mechanism of action involves rapid evaporative cooling upon application to the skin, which temporarily desensitizes local nerve endings and reduces the perception of pain from needle sticks or small incisions. It is non-flammable and intended for topical use only.
- Brand names
- Hurri-Freeze
- Other names
- Topical Anesthetic Skin Refrigerantvapo-coolant
Beyond the preview
Go deeper on Hurri-Freeze.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hurri-Freeze.